Please sign in to follow a disease.

Recurrent diffuse hemispheric glioma, H3 G34-mutant

Clinical trials for Recurrent diffuse hemispheric glioma, H3 G34-mutant explained in plain language.

Never miss a new study

Get alerted when new Recurrent diffuse hemispheric glioma, H3 G34-mutant trials appear

Sign up with your email to follow new studies for Recurrent diffuse hemispheric glioma, H3 G34-mutant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental gene therapy aims to trick immune system to attack brain tumors

Disease control Recruiting now

This early-stage trial tests a new combination treatment for children and young adults (ages 3-39) with recurrent malignant brain tumors that can be surgically removed. The treatment uses two genetically modified viruses injected into the tumor site, plus an oral anti-herpes drug…

Matched conditions: RECURRENT DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT

Phase 1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Recurrent diffuse hemispheric glioma, H3 G34-mutant

Get alerted when new Recurrent diffuse hemispheric glioma, H3 G34-mutant trials appear

Experimental gene therapy aims to trick immune system to attack brain tumors